GSK plc ADR buy Citigroup Inc.
Start price
26.06.24
/
50%
€36.40
Target price
26.06.25
-
Performance (%)
-10.44%
End price
27.06.25
€32.60
Summary
This prediction ended on 27.06.25 with a price of €32.60. The prediction for GSK plc ADR disappointed with a performance of -10.44%. A total of €1.10 was paid as dividends for this prediction. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | -4.147% | -4.147% | 27.607% |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% |
Comments by Citigroup_Inc_ for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten